Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 156   

Articles published

MRK 57.53 +0.03 (0.05%)
price chart
Merck & Co., Inc. (NYSE:MRK): Another Milestone In Immunotherapy
Boston, MA 04/24/2014 (wallstreetpr) - The U.S. Food and Drug Administration (FDA) have approved Merck & Co., Inc. (NYSE:MRK)'s Ragwitek to treat allergy in adult patients. The medicine is a new approach to treating patients suffering allergic rhinitis ...
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences ...
While leader Gilead Sciences (NASDAQ: GILD ) waits on the FDA review for its combination of Sovaldi and levipasvir, and battles questions over Sovaldi's price tag, Merck is producing data on easy-to-treat populations and Bristol-Myers Squibb has turned ...
Related articles »  
Merck & Co., Inc. (NYSE:MRK): Gets The FDA Approval for RAGWITEK�
Dallas, Texas 04/23/2014 (ustradevoice) - Merck & Co., Inc. (NYSE:MRK) have received the FDA Approval for RAGWITEK�.
Merck & Co Inc (NYSE:MRK) � Merck and Award-Winning Actress S. Epatha ...
Merck & Co Inc (NYSE:MRK) [PR Newswire] - WHITEHOUSE STATION, N.J., April 23, 2014 /PRNewswire/ - Merck (MRK), known as MSD outside the United States and Canada, today announced it is teaming up with Emmy and Golden Globe-winning ...
Related articles »  
Drug Manufacture Most Active: Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK ...
Pfizer Inc. (NYSE:PFE) announced top-line results from two pivotal phase 3 trials from the oral treatment Psoriasis Trials (OPT) programme, OPT Pivotal #1 (A3921078) and OPT Pivotal #2 (A3921079), evaluating the efficacy and safety of tofacitinib, an ...
Related articles »  
Brand Face-Off: GlaxoSmithKline plc (ADR) vs. Merck & Co., Inc.
Pharmaceutical giants GlaxoSmithKline plc (ADR) (NYSE:GSK) and Merck & Co., Inc. (NYSE:MRK) have charted different paths during the last year.
Insider Selling: Merck & Co. Insider Unloads 145225 Shares of Stock (MRK)  Ticker Report
Related articles »  
Stocks to Watch Friday: Merck & Co., Inc., Deere & Company, and Toyota Motor ...
Momentum names that made notable moves on Thursday and could continue to do so into Friday's session include pharmaceutical firm Merck & Co., Inc. (NYSE:MRK), machinery concern Deere & Company (NYSE:DE), and automaker Toyota Motor Corp ...
Merck & Co. Price Target Increased to $70.00 by Analysts at MKM Partners ...  Ticker Report
Drug Most active stocks: Pfizer Inc. (NYSE:PFE), Merck & Co (NYSE:MRK ...  Gaining Green
Related articles »  
Merck & Co., Inc. (NYSE:MRK) Reports Positives on its Hepatitis Treatment
Dallas, Texas 04/11/2014 (ustradevoice) - Merck & Co., Inc. (NYSE:MRK) continues to surge in the market after the company announced positive news, on the progress being made on the development of its hepatitis C combo therapies MK-5172 AND ...
Merck Hepatitis C combo pill impresses in Phase II  Seeking Alpha
Merck Data Show Potent Rival to Gilead's Hepatitis C Pill  Bloomberg
Related articles »  
Merck & Co., Inc. (NYSE:MRK)'s Oncology Break-Through MK-3475 Said To ...
It is the case with the breakthrough drug from Merck & Co., Inc. (NYSE:MRK) called the MK-3475 that provides efficient results in the treatment of non-small cell lung cancer (NSCLC).
Related articles »  
Dividend Stocks To Buy Right Now [Merck & Co., Inc., Duke Energy Corp ...
Companies increased dividend payouts by a robust $17.8 billion in Q1 2014, compared to a $14.5 billion increase in Q1 of 2013, a 14.2% year-over-year increase, according to S&P Indices.
Related articles »